Today, the association between wildland firefighting, Valley Fever, and dust exposure has become something of a truism. More ...

Temple University Health System answers five frequently asked questions about the disease ... “There is currently no cure for COPD, since the damage it causes to the lungs is not reversible. There are ...

Laboratory experiments in human and mouse brain organoids ... is mild and exclusively confined to the lungs, it can still provoke inflammation in the brain and impair brain cells’ ability to ...

Reports this week of a teen in British Columbia who tested positive for H5 avian influenza has renewed attention on the virus ...

Oregon confirms its first human bird flu case, the latest in dozens of cases in the U.S. this year. Experts discuss the ...

Researchers have tested a novel therapeutic concept to treat virus-induced lung failure in patients with severe COVID-19 in a phase 2 clinical trial. The approach may also be applicable to other ...

With smog intensity escalating in Lahore at the end of October, affecting its 13 million residents, the Punjab government ...

Controlling a computer with your mind was once pure science fiction, but it's now plausible thanks to brain-computer ...

Myant also acquired the technologies of Swiss deep tech company Osmotex, following a joint venture phase. The technologies enable precise control of moisture and particles in single microchannels, as ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...

The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...